RadNet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RadNet and other ETFs, options, and stocks.

About RDNT

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. 

CEO
Howard G. Berger
CEOHoward G. Berger
Employees
8,546
Employees8,546
Headquarters
Los Angeles, California
HeadquartersLos Angeles, California
Founded
1980
Founded1980
Employees
8,546
Employees8,546

RDNT Key Statistics

Market cap
6.40B
Market cap6.40B
Price-Earnings ratio
-445.78
Price-Earnings ratio-445.78
Dividend yield
Dividend yield
Average volume
1.05M
Average volume1.05M
High today
$84.34
High today$84.34
Low today
$78.88
Low today$78.88
Open price
$79.26
Open price$79.26
Volume
1.16M
Volume1.16M
52 Week high
$85.42
52 Week high$85.42
52 Week low
$45.00
52 Week low$45.00

Stock Snapshot

As of today, RadNet(RDNT) shares are valued at $82.80. The company's market cap stands at 6.4B, with a P/E ratio of -445.78.

As of 2025-11-21, RadNet(RDNT) stock has fluctuated between $78.88 and $84.34. The current price stands at $82.80, placing the stock +5.0% above today's low and -1.8% off the high.

The RadNet(RDNT)'s current trading volume is 1.16M, compared to an average daily volume of 1.05M.

In the last year, RadNet(RDNT) shares hit a 52-week high of $85.42 and a 52-week low of $45.00.

In the last year, RadNet(RDNT) shares hit a 52-week high of $85.42 and a 52-week low of $45.00.

RDNT News

TipRanks 2d
Radnet Executive Cashes In on Major Stock Sale!

New insider activity at Radnet ( (RDNT) ) has taken place on November 19, 2025. TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed in...

Simply Wall St 2d
RadNet Is Up 7.8% After Landmark AI Breast Cancer Screening Study Results Spark Equity Discussion

RadNet, Inc. and its subsidiary DeepHealth recently published results in Nature Health from the nation's largest real-world study of AI-driven breast cancer scr...

RadNet Is Up 7.8% After Landmark AI Breast Cancer Screening Study Results Spark Equity Discussion

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own RDNT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.